Cytyc UK boosted by regio's ThinPrep LBC decision:
This article was originally published in Clinica
Cytyc UK's bid to increase its stake in the national cervical screening market received a boost this week, following the decision by the Southwest region of the National Health Service (NHS) to use the company's ThinPrep liquid-based cytology (LBC) test in all its cervical screening programmes. The decision is to be implemented in all the region's 13 laboratories, which perform some 360,000 tests a year. Over the next five years, these will total an estimated 1.8 million tests. The decision follows a pilot implementation project at Bristol's Southmead Hospital. The technology also received the approval in August 2003 of the National Institute for Clinical Excellence (see Clinica No 1071, p 5). NHS Southwest incorporates the Strategic Health Authorities of Avon, Gloucester & Wiltshire, Devon & Somerset and the South West Peninsula.